Iktos

Description

Iktos builds generative AI and robotics systems for drug discovery, producing platforms for de novo molecule design, retrosynthesis planning and automated synthesis/testing for pharmaceutical teams.

Iktos is located in the Paris ecosystem.

Related

• Isomorphic LabsIsomorphic Labs uses machine learning to transform drug discovery by building predictive and generative AI models for designing molecules…
• TherapanaceaTherapanacea builds AI software for radiotherapy, offering ART-Plan, an AI application suite for automated segmentation, planning, and…
• Qubit PharmaceuticalsQubit Pharmaceuticals develops quantum- and AI-driven molecular modeling platforms and drug discovery tools used to design novel drug…
• HealxHealx builds AI-driven drug discovery and development tools and therapies for rare disease patients, applying AI across discovery,…
• EntalpicEntalpic builds AI-driven materials and molecule discovery platforms that combine machine learning, quantum/atomistic simulation and…
• GenerareGenerare turns unexplored microbial chemistry into screenable molecules for drug discovery by selecting microbes with rare biosynthetic…
• Exvai ResearchExvai Research builds AI-driven quantitative research and investment solutions for financial markets, producing models and tools to help…
• EvotecEvotec provides integrated drug discovery and preclinical development services, delivering CRO/CDMO research platforms, ADME‑Tox, biologics…
• Orakl OncologyOrakl Oncology builds an AIxBio engine that analyzes multimodal patient data and living biological samples to predict drug responses,…